10-QPeriod: Q2 FY2001

BOSTON SCIENTIFIC CORP Quarterly Report for Q2 Ended Jun 30, 2001

Filed August 14, 2001For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed its Form 10-Q for the quarterly period ended June 30, 2001. This report provides a snapshot of the company's financial position and operational status during this period. Investors should note that the filing is primarily a procedural update, confirming the company has met its filing obligations for the preceding 12 months and the past 90 days. The report also details the number of common shares outstanding as of June 30, 2001, which stood at 402,405,387. As this is a quarterly report, a detailed breakdown of financial performance metrics like revenue, net income, and specific segment performances is not immediately available within the provided excerpt. However, the confirmation of regular filings indicates continued compliance with SEC regulations. Investors seeking in-depth financial analysis will need to refer to the full report and accompanying financial statements, which typically include a Management's Discussion and Analysis (MD&A) section for a more comprehensive understanding of the company's results and outlook.

Key Highlights

  • 1Boston Scientific Corporation (BSX) filed its Form 10-Q for the quarter ending June 30, 2001.
  • 2The company confirms it has filed all required reports for the preceding 12 months and the past 90 days.
  • 3As of June 30, 2001, Boston Scientific had 402,405,387 shares of common stock outstanding.
  • 4This filing serves as a confirmation of ongoing regulatory compliance.
  • 5The excerpt does not contain detailed financial performance figures for the quarter.

Frequently Asked Questions

The primary purpose of this 10-Q filing for Boston Scientific Corporation is to report on its financial and operational status for the quarterly period ended June 30, 2001, and to confirm compliance with SEC filing requirements.

As of June 30, 2001, Boston Scientific Corporation had 402,405,387 shares of common stock outstanding.

The provided excerpt of the 10-Q filing does not contain detailed financial performance metrics such as revenue or net income. Investors would need to review the full report, including the financial statements and Management's Discussion and Analysis (MD&A), for this information.

Yes, the company indicated with a checkmark that it has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and has been subject to such filing requirements for the past 90 days.